Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 08 | Option Exercise | 8.65 | 308,250 | 2,667,797 | 605,872 | Jan 12 04:16 PM | ROBERTS EIRY | Chief Medical Officer | Jan 08 | Sale | 111.06 | 2,632 | 292,297 | 15,845 | Jan 12 04:17 PM | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 08 | Sale | 110.22 | 308,250 | 33,973,877 | 441,071 | Jan 12 04:16 PM | ABERNETHY MATT | Chief Financial Officer | Dec 01 | Sale | 94.66 | 1,645 | 155,721 | 11,494 | Dec 02 04:12 PM | BENEVICH ERIC | Chief Commercial Officer | Nov 12 | Sale | 90.71 | 2,257 | 204,723 | 17,405 | Nov 16 06:27 PM | ROBERTS EIRY | Chief Medical Officer | Nov 12 | Sale | 90.74 | 2,257 | 204,810 | 13,477 | Nov 16 06:23 PM | Lloyd-Smith Malcolm | Chief Regulatory Officer | Nov 12 | Sale | 90.73 | 2,257 | 204,776 | 29,002 | Nov 16 06:21 PM | Lippoldt Darin | Chief Legal Officer | Nov 12 | Sale | 90.72 | 2,257 | 204,755 | 30,082 | Nov 16 06:20 PM | Grigoriadis Dimitri E. | Chief Research Officer | Nov 12 | Sale | 90.73 | 2,257 | 204,784 | 81,624 | Nov 16 06:19 PM | GORMAN KEVIN CHARLES | Chief Executive Officer | Nov 12 | Sale | 90.78 | 3,390 | 307,748 | 441,071 | Nov 16 06:16 PM | Gano Kyle | Chief Business Development Off | Nov 12 | Sale | 90.73 | 2,257 | 204,770 | 98,028 | Nov 16 06:11 PM | Cooke Julie | Chief Human Resources Officer | Nov 12 | Sale | 90.73 | 2,257 | 204,778 | 11,580 | Nov 16 06:10 PM | Bozigian Haig P. | Chief Development Officer | Nov 12 | Sale | 90.74 | 2,257 | 204,806 | 152,694 | Nov 16 06:08 PM | ABERNETHY MATT | Chief Financial Officer | Nov 12 | Sale | 90.74 | 2,257 | 204,810 | 10,014 | Nov 16 06:02 PM | BENEVICH ERIC | Chief Commercial Officer | Nov 02 | Option Exercise | 35.99 | 20,595 | 741,214 | 35,969 | Nov 04 06:09 PM | BENEVICH ERIC | Chief Commercial Officer | Nov 02 | Sale | 96.53 | 20,595 | 1,987,972 | 15,374 | Nov 04 06:09 PM | Cooke Julie | Chief Human Resources Officer | Oct 02 | Sale | 95.26 | 987 | 94,022 | 9,549 | Oct 06 04:05 PM | ROBERTS EIRY | Chief Medical Officer | Aug 05 | Sale | 118.84 | 2,257 | 268,225 | 11,446 | Aug 07 07:51 PM | Lloyd-Smith Malcolm | Chief Regulatory Officer | Aug 05 | Sale | 118.86 | 2,257 | 268,277 | 26,971 | Aug 07 07:47 PM | Lippoldt Darin | Chief Legal Officer | Aug 05 | Sale | 118.87 | 2,257 | 268,297 | 28,051 | Aug 07 07:40 PM | Grigoriadis Dimitri E. | Chief Research Officer | Aug 05 | Sale | 118.83 | 2,257 | 268,200 | 79,593 | Aug 07 07:36 PM | GORMAN KEVIN CHARLES | Chief Executive Officer | Aug 05 | Sale | 118.91 | 3,390 | 403,101 | 438,021 | Aug 07 07:29 PM | Gano Kyle | Chief Business Development Off | Aug 05 | Sale | 118.87 | 2,257 | 268,286 | 95,997 | Aug 07 07:24 PM | Cooke Julie | Chief Human Resources Officer | Aug 05 | Sale | 118.91 | 2,257 | 268,383 | 8,661 | Aug 07 07:21 PM | Bozigian Haig P. | Chief Development Officer | Aug 05 | Sale | 118.89 | 2,257 | 268,324 | 150,663 | Aug 07 07:14 PM | BENEVICH ERIC | Chief Commercial Officer | Aug 05 | Sale | 118.85 | 2,257 | 268,254 | 15,374 | Aug 07 06:35 PM | ABERNETHY MATT | Chief Financial Officer | Aug 05 | Sale | 118.90 | 2,257 | 268,356 | 7,983 | Aug 07 06:22 PM | Lippoldt Darin | Chief Legal Officer | Jul 09 | Option Exercise | 35.99 | 1,657 | 59,635 | 27,678 | Jul 10 04:26 PM | Lippoldt Darin | Chief Legal Officer | Jul 09 | Sale | 136.02 | 1,657 | 225,386 | 26,021 | Jul 10 04:26 PM | Lippoldt Darin | Chief Legal Officer | Jun 23 | Option Exercise | 32.99 | 5,000 | 164,950 | 31,021 | Jun 25 04:15 PM | ROBERTS EIRY | Chief Medical Officer | Jun 23 | Option Exercise | 77.81 | 5,000 | 389,050 | 14,416 | Jun 25 04:19 PM | Lippoldt Darin | Chief Legal Officer | Jun 23 | Sale | 130.00 | 5,000 | 650,000 | 26,021 | Jun 25 04:15 PM | ROBERTS EIRY | Chief Medical Officer | Jun 23 | Sale | 130.00 | 5,000 | 650,000 | 9,416 | Jun 25 04:19 PM | Grigoriadis Dimitri E. | Chief Research Officer | Jun 11 | Option Exercise | 35.90 | 5,571 | 199,976 | 77,563 | Jun 15 05:31 PM | Grigoriadis Dimitri E. | Chief Research Officer | May 19 | Option Exercise | 35.99 | 10,000 | 359,900 | 114,741 | May 20 06:59 PM | Grigoriadis Dimitri E. | Chief Research Officer | May 19 | Sale | 126.55 | 42,749 | 5,409,933 | 71,992 | May 20 06:59 PM | Lippoldt Darin | Chief Legal Officer | May 18 | Option Exercise | 32.99 | 5,000 | 164,950 | 31,021 | May 20 07:15 PM | Grigoriadis Dimitri E. | Chief Research Officer | May 18 | Option Exercise | 35.99 | 10,000 | 359,900 | 114,741 | May 20 06:59 PM | Grigoriadis Dimitri E. | Chief Research Officer | May 18 | Sale | 119.98 | 10,000 | 1,199,800 | 104,741 | May 20 06:59 PM | Lippoldt Darin | Chief Legal Officer | May 18 | Sale | 120.00 | 5,000 | 600,000 | 26,021 | May 20 07:15 PM | Bozigian Haig P. | Chief Development Officer | May 12 | Option Exercise | 63.10 | 61,555 | 3,884,054 | 167,204 | May 14 08:09 PM | Bozigian Haig P. | Chief Development Officer | May 12 | Sale | 114.94 | 61,555 | 7,075,396 | 148,633 | May 14 08:09 PM | ABERNETHY MATT | Chief Financial Officer | May 07 | Option Exercise | 73.60 | 15,000 | 1,104,000 | 20,953 | May 11 08:17 PM | ABERNETHY MATT | Chief Financial Officer | May 07 | Sale | 110.21 | 15,000 | 1,653,134 | 5,953 | May 11 08:17 PM | Grigoriadis Dimitri E. | Chief Research Officer | May 07 | Sale | 105.44 | 8,682 | 915,454 | 104,741 | May 11 08:06 PM | SHERWIN STEPHEN A | Director | Apr 28 | Sale | 99.39 | 17,687 | 1,757,966 | 29,861 | Apr 30 04:27 PM | ABERNETHY MATT | Chief Financial Officer | Apr 28 | Sale | 102.49 | 1,741 | 178,435 | 5,953 | Apr 30 04:25 PM | ABERNETHY MATT | Chief Financial Officer | Apr 24 | Sale | 99.52 | 1,934 | 192,467 | 7,694 | Apr 28 08:32 PM | ROBERTS EIRY | Chief Medical Officer | Apr 24 | Sale | 99.47 | 1,934 | 192,376 | 9,416 | Apr 28 08:46 PM | Lloyd-Smith Malcolm | Chief Regulatory Officer | Apr 24 | Sale | 99.45 | 1,934 | 192,329 | 24,941 | Apr 28 08:44 PM | Lippoldt Darin | Chief Legal Officer | Apr 24 | Sale | 99.49 | 1,934 | 192,416 | 26,021 | Apr 28 08:43 PM | Grigoriadis Dimitri E. | Chief Research Officer | Apr 24 | Sale | 99.41 | 1,934 | 192,258 | 113,423 | Apr 28 08:42 PM | GORMAN KEVIN CHARLES | Chief Executive Officer | Apr 24 | Sale | 99.45 | 2,906 | 289,016 | 434,971 | Apr 28 08:41 PM | Gano Kyle | Chief Business Development Off | Apr 24 | Sale | 99.47 | 1,934 | 192,377 | 93,967 | Apr 28 08:40 PM | Cooke Julie | Chief Human Resources Officer | Apr 24 | Sale | 99.46 | 1,934 | 192,364 | 6,631 | Apr 28 08:38 PM | Bozigian Haig P. | Chief Development Officer | Apr 24 | Sale | 99.46 | 1,934 | 192,351 | 148,633 | Apr 28 08:35 PM | BENEVICH ERIC | Chief Commercial Officer | Apr 24 | Sale | 99.45 | 1,934 | 192,338 | 13,344 | Apr 28 08:33 PM | BENEVICH ERIC | Chief Commercial Officer | Apr 15 | Sale | 94.65 | 8,632 | 817,018 | 11,603 | Apr 17 09:48 PM | Lloyd-Smith Malcolm | Chief Regulatory Officer | Feb 10 | Option Exercise | 59.66 | 28,969 | 1,728,147 | 39,127 | Feb 11 07:21 PM | Lloyd-Smith Malcolm | Chief Regulatory Officer | Feb 10 | Sale | 104.56 | 28,969 | 3,029,086 | 23,200 | Feb 11 07:21 PM | ROBERTS EIRY | Chief Medical Officer | Feb 07 | Sale | 103.31 | 1,623 | 167,675 | 7,452 | Feb 11 07:23 PM | Lloyd-Smith Malcolm | Chief Regulatory Officer | Feb 07 | Sale | 103.28 | 1,015 | 104,827 | 23,200 | Feb 11 07:21 PM | Lippoldt Darin | Chief Legal Officer | Feb 07 | Sale | 103.32 | 1,522 | 157,247 | 24,124 | Feb 11 07:17 PM | Grigoriadis Dimitri E. | Chief Research Officer | Feb 07 | Sale | 103.31 | 1,218 | 125,833 | 111,682 | Feb 11 07:16 PM | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 07 | Sale | 103.35 | 3,248 | 335,696 | 432,357 | Feb 11 07:14 PM | Gano Kyle | Chief Business Development Off | Feb 07 | Sale | 103.33 | 1,623 | 167,710 | 91,975 | Feb 11 07:13 PM | Cooke Julie | Chief Human Resources Officer | Feb 07 | Sale | 103.26 | 913 | 94,276 | 4,643 | Feb 11 07:10 PM | Bozigian Haig P. | Chief Development Officer | Feb 07 | Sale | 103.33 | 1,623 | 167,702 | 146,641 | Feb 11 07:09 PM | BENEVICH ERIC | Chief Commercial Officer | Feb 07 | Sale | 103.32 | 2,030 | 209,747 | 20,087 | Feb 11 07:08 PM | ABERNETHY MATT | Chief Financial Officer | Feb 07 | Sale | 103.35 | 2,030 | 209,807 | 5,701 | Feb 11 07:06 PM | BENEVICH ERIC | Chief Commercial Officer | Feb 06 | Sale | 101.48 | 1,395 | 141,561 | 18,262 | Feb 07 06:35 PM | Bozigian Haig P. | Chief Development Officer | Feb 06 | Sale | 101.56 | 1,395 | 141,670 | 145,180 | Feb 07 06:37 PM | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 06 | Sale | 101.56 | 4,343 | 441,068 | 429,436 | Feb 07 06:44 PM | Lippoldt Darin | Chief Legal Officer | Feb 06 | Sale | 101.47 | 1,198 | 121,556 | 22,755 | Feb 07 06:46 PM | Lloyd-Smith Malcolm | Chief Regulatory Officer | Feb 06 | Sale | 101.52 | 1,490 | 151,258 | 22,287 | Feb 07 06:47 PM | Grigoriadis Dimitri E. | Chief Research Officer | Feb 06 | Sale | 101.44 | 803 | 81,456 | 110,587 | Feb 07 06:50 PM | Gano Kyle | Chief Business Development Off | Feb 06 | Sale | 101.41 | 1,000 | 101,413 | 90,514 | Feb 07 06:54 PM | Gano Kyle | Chief Business Development Off | Feb 05 | Sale | 103.05 | 3,690 | 380,262 | 87,204 | Feb 07 06:54 PM | Grigoriadis Dimitri E. | Chief Research Officer | Feb 05 | Sale | 103.15 | 1,618 | 166,894 | 109,320 | Feb 07 06:50 PM | Lloyd-Smith Malcolm | Chief Regulatory Officer | Feb 05 | Sale | 103.05 | 1,948 | 200,733 | 20,455 | Feb 07 06:47 PM | Lippoldt Darin | Chief Legal Officer | Feb 05 | Sale | 102.98 | 1,750 | 180,207 | 21,133 | Feb 07 06:46 PM | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 05 | Sale | 103.09 | 5,449 | 561,726 | 423,351 | Feb 07 06:44 PM | Cooke Julie | Chief Human Resources Officer | Feb 05 | Sale | 103.17 | 605 | 62,417 | 3,821 | Feb 07 06:38 PM | Bozigian Haig P. | Chief Development Officer | Feb 05 | Sale | 103.02 | 2,046 | 210,779 | 143,292 | Feb 07 06:37 PM | BENEVICH ERIC | Chief Commercial Officer | Feb 05 | Sale | 103.03 | 1,954 | 201,311 | 16,279 | Feb 07 06:35 PM |
|